MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Memorial Sloan Kettering Cancer Center

  1. Home
  2. Companies
  3. Memorial Sloan Kettering Cancer Center
  4. Clinical Trials

Clinical Trials Related to Memorial Sloan Kettering Cancer Center

Related studies linked through entity extraction aliases.

NCT00002489

Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors

Status
COMPLETED
Phase
PHASE2

NCT00002484

Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer

Status
COMPLETED
Phase
PHASE1

NCT00002480

Radiation Therapy in Treating Patients With Prostate Cancer

Status
COMPLETED
Phase
PHASE1

NCT00002471

Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Status
COMPLETED
Phase
PHASE2

NCT00002466

Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer

Status
COMPLETED
Phase
PHASE2

NCT00002458

Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission

Status
COMPLETED
Phase
PHASE2

NCT00000136

Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)

Status
COMPLETED
Phase
PHASE3

NCT00000134

Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)

Status
COMPLETED
Phase
PHASE3
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.